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INTRODUCTION:  Campylobacter  is the  leading  cause  of  bacterial  diarrhoeal  illness  worldwide.  Toxic
megacolon  is  a rare  but potentially  devastating  complication.
PRESENTATION  OF  CASE:  A 55 year  old  female  with  liver  cirrhosis,  alcoholism  and  hepatitis  C,  presented
with  severe  colitis  and  stool  specimen  positive  for Campylobacter.  She  developed  septic  shock,  multi-
organ  dysfunction  syndrome  and  toxic  megacolon  unresponsive  to medical  therapy,  and  underwent  a
subtotal  colectomy  with end  ileostomy.  Despite  initial  improvement,  the  patient  died  on postoperative
day  4.olectomy DISCUSSION:  Early  surgical  consultation  is essential  as toxic  megacolon  may  be  complicated  by  perforation
or  uncontrolled  bleeding;  progressive  colonic  dilatation  with  clinical  deterioration  is  also  an  important
indication  for  surgery.
CONCLUSION: Toxic  megacolon  should  be  considered  in a patient  with  Campylobacter  colitis  who  becomes
critically  unwell.  Despite  treatment,  toxic  megacolon  is associated  with  a signiﬁcant  risk of  mortality.
©  2016  The  Author(s).  Published  by  Elsevier  Ltd  on behalf  of IJS  Publishing  Group  Ltd.  This  is  an  open
he  CCaccess  article  under  t
. Introduction
Toxic megacolon is an uncommon but potentially devastating
omplication of colitis. It is characterised by total or segmental
onobstructive colonic dilatation, combined with evidence of sys-
emic toxicity, and has an overall mortality of 19% [1]. Ulcerative
olitis and pseudomembranous colitis are well-recognised precip-
tants and have been reported to account for 77% of cases [2],
owever almost any inﬂammatory condition affecting the colon
ay  lead to this complication [1]. Campylobacter colitis rarely leads
o toxic megacolon and there are only a limited number of pub-
ished case reports [3–14]. This is remarkable, given Campylobacter
s the leading cause of bacterial diarrhoeal illness worldwide [15].
e present a rare case of Campylobacter colitis complicated by
eptic shock, multi-organ dysfunction syndrome (MODS) and toxic
egacolon.
. Presentation of caseA 55 year old female with hepatitis C, intra-venous drug use
nd alcohol abuse complicated by Child-Pugh B liver cirrhosis pre-
ented with abdominal pain, diarrhoea, fevers and confusion. She
∗ Corresponding author at: Royal Brisbane and Women’s Hospital, Herston,
ueensland, 4029, Australia.
E-mail address: mkwo6391@uni.sydney.edu.au (M.  Kwok).
ttp://dx.doi.org/10.1016/j.ijscr.2016.08.030
210-2612/© 2016 The Author(s). Published by Elsevier Ltd on behalf of IJS Publishing 
reativecommons.org/licenses/by-nc-nd/4.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
had no history of colonic disease. Computed tomography (CT) of the
abdomen demonstrated mildly dilated proximal large bowel with-
out fat stranding or colonic wall thickening. Stool PCR was positive
for campylobacter species. Treatment with azithromycin, ceftriax-
one, metronidazole, intravenous ﬂuids and electrolyte replacement
was commenced.
She continued to deteriorate and subsequently had a long
admission to the intensive care unit with aspiration pneumonitis,
type 2 myocardial infarction, renal failure and metabolic acidosis,
requiring intubation, vasopressors and dialysis.
Transthoracic echocardiography, lumbar puncture, blood cul-
tures and CT scans of the head, chest, abdomen and pelvis did not
demonstrate an alternative source of sepsis and antibiotics were
escalated to piperacillin/tazobactam.
On day 16 of admission she developed bloody diarrhoea with
ongoing refractory multi-organ dysfunction. CT abdomen demon-
strated colonic wall thickening most prominent in the sigmoid and
rectum, but there was no gross dilatation, intramural gas, free gas
or obvious bleeding points. Upper endoscopy excluded varices and
ulcers. At this point, the patient was  transferred to our tertiary hos-
pital for ongoing intensive care management and surgical review.
An emergent laparotomy was  performed. Intraoperatively,
viable mildly dilated colon and clear ascites were encountered.
There was  no evidence of ischaemia, necrosis or perforation. The
liver was  nodular and the remainder of the bowel was normal.
Flexible sigmoidoscopy was performed on table and demonstrated
discontinuous areas of non-bleeding ulcerated mucosa in the sig-
Group Ltd. This is an open access article under the CC BY-NC-ND license (http://
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big. 1. Sigmoidoscopy demonstrated discontinuous areas of non-bleeding mucosal
lceration which can be consistent with infectious colitis.
oid colon (Fig. 1); biopsies were taken. The case was  discussed
ith intensive care and infectious diseases teams and it was felt
he ﬁndings were consistent with infective colitis with septic shock
nd MODS. The patient was returned to ICU for ongoing intensive
are management and antibiotics were changed to daptomycin,
iproﬂoxacin, ﬂuconazole and metronidazole.
Over the next 12 h the patient deteriorated with worsening
aemodynamic instability, requiring increasing amounts of nora-
renaline and vasopressin. A re-look laparotomy was  performed,
hich demonstrated grossly dilated colon, without perforation or
ull thickness ischemia. A subtotal colectomy was performed and
n end ileostomy and distal sigmoid mucous ﬁstula were fashioned.
Immediate improvement was noted postoperatively; vaso-
ressin was ceased and her noradrenaline infusion was  halved.
ntil post-operative day 3 she continued to improve however
he again developed escalating vasopressor requirements, acido-
is, liver failure and respiratory failure. She died on postoperative
ay 4.
Histology of the pathological specimens showed features of
nfectious colitis and ischemia. Macroscopically, multiple discrete
reas of mucosal ulceration were noted in the ascending, transverse
nd descending colon. There was no overtly infarcted bowel or
seudomembranes. Microscopically, the ulcerated mucosa showed
ongestion, neutrophilic inﬁltration and ﬁbrin thombi. There was
o architectural distortion and cryptitis and crypt abscesses were
ot prominent features. Features typical for inﬂammatory bowel
isease were absent.
. Discussion
Toxic megacolon is a serious condition with an overall mortal-
ty up to 19% and up to 41% mortality when perforation occurs
1]. Campylobacter colitis complicated by toxic megacolon is rare
nd to our knowledge, there are only twelve case reports in the
iterature, and none published since 2000 [3–14].
In previous case reports, the diagnosis of toxic megacolon was
ypically preceded by a prolonged diarrhoeal illness of at least
0 days and the majority occurred in healthy young patients, in con-
rast to our patient. Five cases reported total or subtotal colectomies
erformed for actual colonic perforation, and one case for intraop-
rative ﬁndings suggestive of imminent perforation [3,5,8,11–13].
ll of these patients recovered uneventfully postoperatively, but
one of these patients were reported to have any signiﬁcant comor-
idities. The importance of differentiating inﬂammatory bowelPEN  ACCESS
ery Case Reports 27 (2016) 141–143
disease from infective colitis has been highlighted, since toxic
megacolon of infective aetiology does not often require operative
management and may  be worsened by corticosteroids [3,5,10,13].
The diagnosis of toxic megacolon was  established clinically. A
commonly used set of diagnostic criteria requires radiographic evi-
dence of colonic dilatation and at least three of the following:
Fever >38 ◦ Celsius, heart rate >120 beats per minute, white cell
count >10500/microL or anaemia [16]. Furthermore, at least one of
the following is also required: dehydration, altered mental status,
electrolyte disturbance or hypotension [16]. The clinical signs of
systemic toxicity differentiate toxic megacolon from other patho-
logical processes which can also lead to colonic dilatation, such
as Ogilvie syndrome, volvulus or Hirschprung’s disase [17]. In the
case presented, evidence of gross colonic dilatation was  apparent
intraoperatively in addition to the profound MODS evident in the
intensive care unit.
The diagnosis of toxic megacolon is not an absolute indication
for surgery [17]. The underlying cause of colitis should be treated
to restore colonic motility and prevent perforation [17]. Fluid and
electrolyte disturbances need to be corrected, signs of toxaemia
need to be addressed and anti-motility agents need to be with-
drawn [17,18]. Although toxic megacolon precipitated by infectious
colitis often does not require surgery, early surgical consultation is
essential and operative management should be considered in those
not improving [3,13,18].
Indications for surgery include perforation, uncontrolled bleed-
ing, and progressive colonic dilatation with clinical deterioration
[1,2,16]. The operation of choice is a subtotal colectomy with end
ileostomy and Hartmann’s pouch or sigmoid mucous ﬁstula [2].
Compared with emergent total proctocolectomy, emergent subto-
tal colectomy is associated with a lower mortality and morbidity
and also offers an opportunity for subsequent reconstruction of
alimentary continuity [1]. The resected specimen can be sent for
deﬁnitive diagnosis of the colitis. The procedure removes the sep-
tic focus and prevents further bacterial translocation, which can
result in rapid clinical improvement.
The decision to perform a colectomy in the previously pub-
lished cases was  relatively straightforward as they were relatively
young and healthy. In this patient, the decision was difﬁcult and
initial surgery was  delayed due to her co-morbidities: the mor-
tality in Child-Pugh B cirrhosis patients undergoing emergency
surgery is 38% [19]. For these reasons, at the initial laparotomy
where the colon was dilated but relatively normal in appear-
ance, it was  felt that performing colectomy at the time would
increase morbidity and mortality risk. However, following the
initial laparotomy, worsening systemic toxicity despite maximal
medical management meant death was  likely imminent. There-
fore, a second laparotomy and a subtotal colectomy was performed,
and an immediate initial clinical improvement was observed. Ulti-
mately, the patient’s demise indicates her clinical state was likely
irretrievable at the time of surgery.
4. Conclusion
Toxic megacolon needs to be considered in patients with
Campylobacter colitis who  become critically unwell. Early surgical
consultation is essential, as the disease can be complicated by per-
foration and uncontrolled bleeding: progressive colonic dilatation
with worsening systemic toxicity is also an important indication
for surgery. Despite treatment, toxic megacolon is associated with
a signiﬁcant risk of mortality, especially in patients with multiple
unfavourable comorbidities.Conﬂicts of interest
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